Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age

Vaccine

Volumn 28, Issue 1, 2009, Pages 71-78

  Prymula, Roman ^a   Kriz, Pavla ^b   Kaliskova, Eva ^c   Pascal, Thierry ^d   Poolman, Jan ^d   Schuerman, Lode ^d  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c GLAXOSMITHKLINE   (United Kingdom)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Acute otitis media; Haemophilus influenzae; Nasopharyngeal carriage; Pneumococcal protein D conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

HEPATITIS A VACCINE; PNEUMOCOCCUS PROTEIN D CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ACUTE OTITIS MEDIA; ARTICLE; BACTERIAL COLONIZATION; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAEMOPHILUS INFLUENZAE; HEPATITIS A; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; STRAIN IDENTIFICATION; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; VACCINATION; VIRUS IDENTIFICATION; VIRUS STRAIN;

BACTERIAL PROTEINS; CARRIER PROTEINS; CARRIER STATE; CHILD, PRESCHOOL; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FEMALE; HAEMOPHILUS INFECTIONS; HUMANS; IMMUNOGLOBULIN D; INFANT; LIPOPROTEINS; MALE; NASOPHARYNX; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; PROSPECTIVE STUDIES; VACCINES, CONJUGATE;

EID: 70649103013     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.113     Document Type: Article

References (49)

1. Schwartz J.S. Pneumococcal vaccine: clinical efficacy and effectiveness. Ann Intern Med 96 (1982) 208-220
2. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
3. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
4. Leibovitz E., Jacobs M.R., and Dagan R. Haemophilus influenzae a significant pathogen in acute otitis media. Pediatr Infect Dis J 23 (2004) 1142-1155
5. Akkoyunlu M., Ruan M., and Forsgren A. Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun 59 (1991) 1231-1238
6. Janson H., Ruan M., and Forsgren A. Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains. Infect Immun 61 (1993) 4546-4552
7. Munson Jr. R.S., and Sasaki K. Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase. J Bacteriol 175 (1993) 4569-4571
8. Song X.M., Forsgren A., and Janson H. The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains. Infect Immun 63 (1995) 696-699
9. Janson H., Melhus A., Hermansson A., and Forsgren A. Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model. Infect Immun 62 (1994) 4848-4854
10. Janson H., Carlén B., Cervin A., Forsgren A., Magnusdottir A.B., Lindberg S., et al. Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures. J Infect Dis 180 (1999) 737-746
11. Fan X., Goldfine H., Lysenko E., and Weiser J.N. The transfer of choline from the host to the bacterial cell surface requires glpQ in Haemophilus influenzae. Mol Microbiol 41 (2001) 1029-1036
12. Lysenko E.S., Gould J., Bals R., Wilson J.M., and Weiser J.N. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect Immun 68 (2000) 1664-1671
13. Weiser J.N., Pan N., McGowan K.L., Musher D., Martin A., and Richards J. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med 187 (1998) 631-640
14. Poolman J.T., Bakaletz L., Cripps A., Denoel P.A., Forsgren A., Kyd J., et al. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 19 Suppl. 1 (2001) S108-S115
15. Bakaletz L.O., Kennedy B.J., Novotny L.A., Duquesne G., Cohen J., and Lobet Y. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect Immun 67 (1999) 2746-2762
16. Novotny L.A., Jurcisek J.A., Godfroid F., Poolman J.T., Denoël P.A., Lauren O., et al. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae. Vaccine 24 (2006) 4804-4811
17. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 (2006) 740-748
18. Käyhty H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals 22 (1994) 397-402
19. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W., and Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 171 (1995) 93-98
20. Obaro S.K., Adegbola R.A., Banya W.A., and Greenwood B.M. Carriage of pneumococci after pneumococcal vaccination. Lancet 348 (1996) 271-272
21. Dagan R., Muallem M., Melamed R., Leroy O., and Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 16 (1997) 1060-1064
22. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., and Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180 (1999) 1171-1176
23. Dagan R., Givon-Lavi N., Zamir O., Sikuler-Cohen M., Guy L., Janco J., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185 (2002) 927-936
24. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Reid R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 196 (2007) 1211-1220
25. Kilpi T.M., Syrjänen R., Palmu A., Herva E., Eskola J., Mäkelä P.H., et al. Parallel evaluation of the effect of a 7-valent pneumococcal conjugate vaccine (PNCCRM) on pneumococcal (PNC) carriage and acute otitis media (AOM). 19th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID 2001). Istanbul, Turkey, March 26-28 (2001)
26. Schuerman L., Prymula R., Henckaerts I., and Poolman J. ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media. Vaccine 25 (2006) 1953-1961
27. Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H., et al. Manual of clinical microbiology. Sixth edition (1995), American Society of Microbiology, Washington, DC
28. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 43 (1976) 1053-1059
29. Murphy T.F., Brauer A.L., Sethi S., Kilian M., Cai X., and Lesse A.J. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae. J Infect Dis 195 (2007) 81-89
30. McCrea K.W., Xie J., LaCross N., Patel M., Mukundan D., Murphy T.F., et al. Relationships of nontypeable Haemophilus influenzae strains to hemolytic and nonhemolytic Haemophilus haemolyticus strains. J Clin Microbiol 46 (2008) 406-416
31. García-Rodríguez J.A., and Martínez M.J.F. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother 50 S2 (2002) 59-73
32. Shurin P.A., Rehmus J.M., Johnson C.E., Marchant C.D., Carlin S.A., Super D.M., et al. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high risk children. J Pediatr 123 (1993) 801-810
33. Yeh S.H., Zangwill K.M., Lee H., Changa S.J., Wong V.I., Greenberg D.P., et al. Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup B and nasopharyngeal carriage in infants. Vaccine 21 (2003) 2627-2631
34. Ghaffar F., Barton T., Lozano J., Muniz L.S., Hicks P., Gan V., et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis 39 (2004) 930-938
35. van Kempen M.J.P., Vermeiren J.S., Vaneechoutte M., Claeys G., Veenhoven R.H., Rijkers G.T., et al. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?. Int J Pediatr Otorhinolaryngol 70 (2006) 275-285
36. Sandstedt S.A., Zhang L., Patel M., McCrea K.W., Qin Z., Marrs C.F., et al. Comparison of laboratory-based and phylogenetic methods to distinguish between Haemophilus influenzae and H. haemolyticus. J Microbiol Methods 75 (2008) 369-371
37. Käyhty H., Auranen K., Nohynek H., Dagan R., Mäkelä H., and the Pneumococcal Carriage group. Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines 5 5 (2006) 651-668
38. Mohle-Boetani J.C., Ajello G., Breneman E., Deaver K.A., Harvey C., Plikaytis B., et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 12 (1993) 589-593
39. Adegbola R.A., Mulholland E.K., Secka O., Jaffar S., and Greenwood B.M. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. J Infect Dis 177 (1998) 1758-1761
40. Ghaffar F., Friedland I., and McCracken G.H. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J 18 7 (1999) 638-646
41. Bogaert D., de Groot R., and Hermans P.W.M. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4 (2004) 144-154
42. Klugman K.P. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis 1 (2001) 85-91
43. Kilpi T., Ahman H., Jokinen J., Lankinen K.S., Palmu A., Savolainen H., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 37 (2003) 1155-1164
44. Block S.L., Hedrick J., Harrison C.J., Tyler R., Smith A., Findlay R., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23 (2004) 829-833
45. Casey J.R., and Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 23 (2004) 824-828
46. Lakshman R., Murdoch C., Race G., Burkinshaw R., Shaw L., and Finn A. Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child 88 (2003) 211-214
47. Madhi S.A., Adrian P., Kuwanda L., Cutland C., Albrich W.C., and Klugman K.P. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae-and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization-in HIV-infected and HIV-uninfected children. J Infect Dis 196 (2007) 1662-1666
48. Millar E.V., O'Brien K.L., Watt J.P., Bronsdon M.A., Dallas J., Whitney C.G., et al. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis 43 (2006) 8-15
49. Mukundan D., Ecevit Z., Patel M., Marrs C.F., and Gilsdorf J.R. Pharyngeal colonization dynamics of Haemophilus influenzae and Haemophilus haemolyticus in healthy adult carriers. J Clin Microbiol 45 (2007) 3207-3217